EDGAR Filing Documents for 0001753926-24-000356

Form 8-K - Current report:

SEC Accession No. 0001753926-24-000356

Filing Date

2024-02-22

Accepted

2024-02-22 16:05:49

Documents

Period of Report

2024-02-15

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	g084068_8k.htm iXBRL	8-K	57981
2	EXHIBIT 1.1	g084068_ex1-1.htm	EX-1.1	306712
3	EXHIBIT 1.2	g084068_ex1-2.htm	EX-1.2	22202
4	EXHIBIT 3.1	g084068_ex3-1.htm	EX-3.1	77425
5	EXHIBIT 3.2	g084068_ex3-2.htm	EX-3.2	188261
6	EXHIBIT 4.1	g084068_ex4-1.htm	EX-4.1	120888
7	EXHIBIT 99.1	g084068_ex99-1.htm	EX-99.1	14703
8	EXHIBIT 99.2	g084068_ex99-2.htm	EX-99.2	12016
	Complete submission text file	0001753926-24-000356.txt		1131194

Data Files

Seq	Description	Document	Type	Size
9	XBRL SCHEMA FILE	chro-20240215.xsd	EX-101.SCH	3021
10	XBRL LABEL FILE	chro-20240215_lab.xml	EX-101.LAB	34240
11	XBRL PRESENTATION FILE	chro-20240215_pre.xml	EX-101.PRE	22363
22	EXTRACTED XBRL INSTANCE DOCUMENT	g084068_8k_htm.xml	XML	3854

Mailing Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902

Business Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902 9176446313

Chromocell Therapeutics Corp (Filer) CIK: 0001919246 (see all company filings)